Chief Executive Officer Lee Whan Chul said L&C Bio developed the technology around five years ago and holds patents in South ...
L&C Bio stock jumps 12% on plans for an Ozempic fix made from donated human fat, backed by patents in three markets.
Ozempic is an injectable semaglutide medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes ...
He practices as a sleep medicine specialist and weight management physic... See Full Bio Rafael Sepulveda Acosta, M.D. Sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results